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DNA bindingIn the mouse, ZFP57 contains three classical Cys2His2 zinc ﬁnger domains (ZF) and recognizes the
methylated TGCmetCGC target sequence using the ﬁrst and the second ZFs. In this study, we demon-
strate that the human ZFP57 (hZFP57) containing six Cys2His2 ZFs, binds the same methylated
sequence through the third and the fourth ZFs, and identify the aminoacids critical for DNA inter-
action. In addition, we present evidences indicating that hZFP57 mutations and hypomethylation
of the TNDM1 ICR both associated with Transient Neonatal Diabetes Mellitus type 1 result in loss
of hZFP57 binding to the TNDM1 locus, likely causing PLAGL1 activation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Transient Neonatal Diabetes Mellitus type 1 (TNDM1; OMIM
601410) is a rare form of diabetes, in which hyperglycaemia remits
at amedian age of approximately 3months, but in half of the cases it
recurs in adolescence or adulthood. It is caused by overexpression of
the imprinted genesPLAGL1 andHYMAI[1,2] onhumanchromosome
6q24. The expression of these genes is normally restricted to the
paternal allele as a result of maternal DNA methylation of the pro-
moter region (TNDM1 imprinted control region or TNDM1 ICR).
TNDM1 is not associated with mutations of PLAGL1 or HYMAI, but
rather with their overexpression via three known mechanisms: (1)
paternal uniparental disomyof chromosome6 (40%), (2) duplication
of the imprinted TNDM1 region on chromosome 6q24 (32%), or (3)
relaxation of imprinting with maternal hypomethylation of the
TNDM1 ICR in the absence of any detectable DNA or chromosome
anomaly in cis (28%). Despite their common epimutation, patients
with hypomethylation of the TNDM1 ICR are clinically heteroge-neous and canbe divided in two subgroups: about 50%havenoother
epimutations while in the others loss of methylation at 6q24 is part
of a complex hypomethylation at multiple imprinted loci (hypome-
thylation at imprinted loci, HIL). The majority of these TNDM1 HIL
cases were found to have recessive loss of function mutations in
the gene encoding the zinc ﬁnger transcription factor ZFP57 on hu-
man chromosome 6p22.3 [3].
The human ZFP57 (hZFP57) is a protein of 516 amino acids (the
mouse homologue has 421 amino acids), including a predicted
Kruppel-associated box (KRAB) domain and six complete classical
Cys2His2 zinc ﬁngers (ZFs); in contrast only three of the classical
Cys2His2 ZFs are present in the mouse protein [4], with the ﬁrst
and second ZFs of the mouse protein being homologous to the sec-
ond and third of the human.
Loss of ZFP57 function in the developing mouse zygote is par-
tially lethal, while eliminating both maternal and zygotic functions
of ZFP57 causes complete embryonic lethality [5]. The Zfp57
knockout mouse model conﬁrms that in the mouse, as in human,
the protein is required for post-fertilization maintenance of the
parent of origin-speciﬁc methylation of the ICRs. Human ZFP57
mutations affect several maternally methylated ICRs while inacti-
vation of the mouse Zfp57 causes imprinting defects at both mater-
nally and paternally methylated loci. In mice, absence of ZFP57 also
results in defective establishment of maternal methylation at the
imprinted Snrpn locus [3,5].
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ICRs where it recruits the corepressor KAP1, the H3K9 methyl-
transferase SETDB1 and the heterochromatin protein HP1-gamma
[6]. This protein complex was shown to be required for maintain-
ing the parent of origin-speciﬁc DNA methylation, histone
H3K9me3 and gene expression at many of these loci [6–8]. Recruit-
ment of ZFP57/KAP1 at the ICRs is mediated by ZFP57 recognition
of a methylated TGCmetCGC hexanucleotide motif; the ﬁrst and sec-
ond Cys2His2 ZFs of the mouse protein are sufﬁcient for the high
afﬁnity recognition of this DNA target site [6].
Here, we demonstrate that similarly to the mouse ﬁrst and sec-
ond ZFs, the third and fourth ZFs of hZFP57 speciﬁcally recognizes
the TGCmetCGC hexanucleotide. In addition, we deﬁne the zinc ﬁn-
ger residues that are important for hZFP57–DNA interaction and
demonstrate that two hZFP57 mutations (R248H and H277N) asso-
ciated with TNDM1 affect the binding to methylated DNA. By
showing that in the mouse ZFP57 represses Plagl1 expression and
that hZFP57 binds in vitro three DNA sequences of the TNDM1
ICR in a DNAmethylation-dependent manner, we indicate a molec-
ular mechanism by which genetic and epigenetic mutations cause
TNDM1.2. Materials and methods
2.1. Cloning and Puriﬁcation of the Proteins
DNA fragments encoding the different segments of the hZFP57
protein were generated by PCR from cDNA hIPS. Oligonucleotides
were synthesized on the basis of the published sequence
(NP_001103279.2) which replaced the original XP_294093 which
lacks 20 residues at the N-terminus. The following oligonucleotides
were used as primers: primer 1, 50-CGGGATCCGGGCCACCCTTTT
TTTGCTACACCTGTGGCAAATG-30, and primer 2, 50-AACATGGTC
GACTCACACTGGCTCCTGGTTTTGGTGTATC-30, for hZFP57zf1-4 (res-
idues 172–287). In order to generate the hZFP57zf3-4 (residues
227–287), we substituted the Cys232 of the protein with a phenyl-
alanine, present in the mouse protein, by PCR-mediated mutagen-
esis [9]. This substitution increased the stability and easy of
handling of the protein without changing its DNA binding proper-
ties (Supplementary Fig. 1) and so we used it in the hZFP57zf3-4
protein and in all the mutants. For cloning of the coding sequence
for hZFP57zf3-4, we used primer 3, 50-CGGGATCCGGGGAGAGGC
CCTTCTTTTGCACGCTCTG-30, and primer 2. The plasmid including
the coding sequence of the hZFP57zf3-4 was used as a template
to generate by PCR-mediated mutagenesis the ZF3 point mutants
of position 1 (D242A), +2 (S244A), +3 (G245A) and +6 (R248A)
and the ZF 4 point mutants in position 1 (D270A), +2 (S272A),
+3 (E273A) and +6 (R276A). The primers 4, 50-CGGGATCCGGGGA-
GAGGCCCTTCTTTTGCACGCTCTGTGACAAGACCTACTGTGCTGCTTCT
GGAC-30, and primer 2 were used to generate hZFP57zf3-4D242A; pri-
mer 5, 50-CGGGATCCGGGGAGAGGCCCTTCTTTTGCACGCTCTGTGA-
CAAGACCTACTGTGATGCTGCTGGACTAAGTC-30, and primer 2 to
generate hZFP57zf3-4S244A; primer 6, 50-CGGGATCCGGGGAGAGGCC
CTTCTTTTGCACGCTCTGTGACAAGACCTACTGTGATGCTTCTGCAC-
TAAGTCGTC-30, and primer 2 to generate hZFP57zf3-4G245A; primer
7, 50-CGGGATCCGGGGAGAGGCCCTTCTTTTGCACGCTCTGTGACAA-
GACCTACTGTGATGCTTCTGGACTAAGTGCTCACCGCCGCG-30, and pri-
mer 2 to generate hZFP57zf3-4R248A; primer 3 and primer 8, 50-AACA
TGGTCGACTCACACTGGCTCCTGGTTTTGGTGTATCTTCTGGTGGCGTTT
GAGCTCAGACTGGGCCCGGAAGCTC-30, for hZFP57zf3-4D270A; primer
3 and primer 9, 50-AACATGGTCGACTCACACTGGCTCCTGGTTTT
GGTGTATCTTCTGGTGGCGTTTGAGCTCAGCCTGGTCCCGG-30, for
hZFP57zf3-4S272A; primer 3 and primer 10, 50-AACATGGTCGACTCA-
CACTGGCTCCTGGTTTTGGTGTATCTTCTGGTGGCGTTTGAGCGCAGA
CTGGTCC-30, for hZFP57zf3-4E273A; primer 3 and primer 11, 50-AACATGGTCGACTCACACTGGCTCCTGGTTTTGGTGTATCTTCTGGTGG
GCTTTGAGCTCAG-30, for hZFP57zf3-4R276A. Primer 1, primer R248H
for, 50-GGACTAAGTCATCACCGCCGCGTCCATCTGGGTTACCGG-30, primer
R248H rev 50-GATGGACGCGGCGGTGATGACTTAGTCC AGAAGC-30
and primer 2 were used to generate by a double-step PCR-
mediated mutagenesis reaction the TND mutant hZFP57zf1-4R248H;
primer 1 and primer 12, 50-AACATGGTCGACTCACACTGGCTCCTG
GTTTTGGTGTATCTTCTGGTTGCGTTTGAGC-30, for the TND mutant
hZFP57zf1-4H277N.
All of the PCR products were digested with the restriction en-
zymes BamHI and SalI and cloned into a BamHI/SalI-digested
pGEX-4T-3 (GE Healthcare) expression vector and the proteins
were expressed as a glutathione S-transferase (GST) fusion. The fu-
sion proteins were expressed in the Escherichia coli BL21 host
strain, induced for 2 h in the presence of 1 mM IPTG at 37 C. The
GST fusion proteins were puriﬁed as previously published [10].
2.2. Electrophoretic Mobility Shift Analysis (EMSA)
10 pmol of the puriﬁed proteins were incubated for 10 min on
ice with 2.5 pmol of the speciﬁed duplex oligonucleotides in the
presence of 25 mM HEPES (pH 7.9), 50 mM KCl, 6.25 mM MgCl2,
1% NP-40 and 5% glycerol. After incubation, the mixture was
loaded on a 5% polyacrylamide gel (29:1 acrylamide:bisacrylamide
ratio) and run in 0.5% TBE (200 V for 75 min). The gels were than
stained with SYBR Green (Invitrogen) and acquired with Typhoon
Trio++ scanner (GE Healthcare). The 50-TGCCGC-30 DNA probe used
in the EMSA experiments was obtained by annealing the following
single strands oligonuceotides: 50-GTAATATTGCCGCAGTAATA-30
and 50-TATTACTGCGGCAATATTAC-30; the 50-TGCmetCGC-30 DNA
probe was obtained by annealing the following methylated single
strands oligonucleotides: 50-GTAATATTGCmetCGCAGTAATA-30 and
50-TATTACTGmetCGGCAATATTAC-30.
2.3. DNA methylation and gene expression analyses
1 lg genomic DNA extracted from mouse wild-type ESCs (line
A3) and Zfp57 / ESCs (clones 2E9 & 1A12, [11,12] was treated
using the EpiTect Bisulﬁte Kit (Qiagen). Sodium bisulﬁte converts
unmethylated cytosine residues to uracil, while methylated cyto-
sine is unchanged. The Plagl1 ICR (mm9 Chrm10:12810201-
12811599) was ampliﬁed by PCR using bisulﬁte converted DNA
as template. The primers used were as follows: Plagl1_BIS_F1 50-
AYGTAGATTTTTAGATTGAGTTGAGGTTAT-30 and Plagl1_BIS_R1 50-
CCTACCAAACRAATAAAATTAAAAAAC-30. The PCR products were
cloned in Topo pCR2.1 vector (Topo-TA cloning kit, Invitrogen)
and the clones sequenced. For expression analysis, we extracted
RNA from mouse ESCs lines A3, 2E9 and 1A12, using the Trizol re-
agent (Invitrogen). cDNA was synthesized using 1 lg of total RNA
and Quantitech Reverse Transcription Kit (Qiagen), according to
the protocol of the manufacturer. Plagl1 expression was examined
by iQ SYBR Green Supermix (BioRad) quantitative real-time RT-
PCR. Reactions were run on a CFX96 Real-Time System + C1000
Thermal Cycler (Biorad) using the default cycling conditions. Rela-
tive expression was determined using the DDCT method, and gene
expression values were normalized against the expression of GAP-
DH. The PCR primers were as follows: Plagl1RTcDNA1for: 50-GC
CTCACAGCTGGCTTTCCTGCTCTCAC-30; Plagl1RTcDNA1rev: 50-GTG
GGGAGTCACTACAGCCTGACTCCAG-30; GapdhRTFor: 50-GCAAGGC
TTCCGTGCTCTCGAGAGAG-30; GapdhRTRev: 50-GCCCGAGGACAA-
TAAGGCTCAAGGGC-30.
2.4. Chromatin immuno-precipitation (ChIP)
Mouse ES cells were cultured at 80% conﬂuence and cross-
linked with 1% formaldehyde for 10 min at room temperature.
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extracts were prepared for the chromatin immunoprecipitations.
The fragmented chromatin from 7  106 cells was used for each
reaction. DNA was immunoprecipitated with 8 lg of anti-ZFP57
(by Abcam Ab 45341) and with 7 lg of anti-KAP1 (by Abcam Ab
22553). DNA from the immunoprecipitates or from 1% of input
was analyzed by real-time PCR using the following primers speciﬁc
for CpGi 36 and CpGi 72: Plagl1CpG36F: 50-TCTTTGGGGTCCAAG-
CAA-30; Plagl1CpG36R 50-ACGAGGTCGTTCCCTTGTC-30; Plagl1CpG
72F: 50-TGAGTCCGGCTAGGGTAGG-30; Plagl1CpG72R: 50-GAG-
CCTTTTGCTGCATCTCT-30. The human embryonal carcinoma
2102Ep cells were processed for ChIP using the MAGnify Chroma-
tin Immunoprecipitation System (Life Technologies). Brieﬂy, the
cells were ﬁxed with 1% formaldehyde for 10 min at room temper-
ature and the chromatin was sheared by sonication to an average
fragment size of 100–500 bp with the Covaris instrument. DNA
was immunoprecipitated with 5 lg of anti-KAP1 (by Abcam
Ab10483) according to the MAGnify kit protocol. ChIP and input
DNA were ampliﬁed by qPCR using primers speciﬁc for the TNDM1
ICR (CpGi 118): F-GTCACGTGGCAGGAGGAG and R-CTGTACCTGG
GCGACCTTG, and for the upstream CpGi 113: F-GGCTAAGCTGGC-
ACTTGAGA and R-GTCTGCAGCTCTTCGCTTCT. A fraction of the in-
put chromatin (1%) was processed together with a control rabbit
anti-IgG and qChIP values were given as percent of input.
3. Results
Despite numerous data suggesting similar functions in vivo of
human (hZFP57) and mouse ZFP57 (mZFP57) [3,5,13], these pro-
teins share poor sequence identity outside the regions encompass-
ing the KRAB domain (that binds the cofactor KAP1) and the thirdFig. 1. Alignment of hZfp57 and mZfp57 sequences. The KRAB domain and the Cys2Hi
domains are indicated. The TNDM1 associated mutations are also indicated. Amino acids
are indicated by double and single dots, respectively.and fourth human and ﬁrst and second mouse ZFs (Fig. 1). In pro-
teins containing multiple ﬁngers, it is clear that adequate speciﬁc-
ity and afﬁnity can be provided by a few critical ﬁngers, usually
separated by a canonical 7 amino acids spacer [14,15]. In hZFP57
the 6 ZFs are divided in two distant clusters of canonically spaced
domains, comprising the NH2-terminal four and the COOH-termi-
nal two ZFs. To deﬁne the minimal region able to bind DNA, frag-
ments encoding the four NH2-terminal ZFs of hZFP57
(hZFP57zf1-4) and ZFs 3 and 4 (hZFP57zf3-4) were cloned into
the pGEX-4T-3 expression vector. The proteins were expressed
and tested by EMSA on oligonucleotides containing the TGCCGC
motif. We observed that hZFP57zf1-4 as well as hZFP57zf3-4 are
able to bind this DNA sequence (Fig. 2A and B) with a clear prefer-
ence for the methylated site, indicating that the two conserved ZFs
play a critical role for DNA interaction. Notably, EMSA performed
with hemimethylated oligonucleotides showed that the methyl-
ated C recognized by hZFP57 is on the reverse strand of the DNA
target (Fig. 2B lanes 3 and 4).
All the structural and functional studies conducted on animal
zinc ﬁnger proteins interacting with DNA suggest that these motifs
employ the residue that immediately precedes the a-helix (posi-
tion 1), as well the second (+2), third (+3) and sixth (+6) residues
of the helix to contact the base pairs [14,16]. In order to demon-
strate if these residues were also important for the interaction of
hZFP57 with methylated DNA, EMSAs were performed with
hZFP57zf3-4 containing alanine substitutions of the amino acids
in positions 1, +2, +3, +6 of ZF3 (D242, S244, G245 and R248)
and ZF4 (D270, S272, E273 ad R276). The results shown in
Fig. 3A and B clearly indicate that all the single mutations except
E273A reduce protein–DNA binding afﬁnity; a dramatic effect is
observed with the ZF3 mutants in position +2 (hZFP57zf3-4S244A),s2 ZFs domains are underlined in the two sequences. The six Cys2His2 human ZFs
identities are indicated by asterisks. Conservative and non-conservative homologies
A B
Fig. 2. (A) EMSA analysis of hZFP57zf1-4 DNA binding capability (B) EMSA analysis
of hZFP57zf3-4 DNA binding capability. The sequences of the forward strands of the
oligonucleotides used as probes are indicated. The 50-TGCmetCGC-30 for and 50-
TGCmetCGC-30 rev oligonucleotides are methylated only on the forward and reverse
strands, respectively.
A B
Fig. 3. (A) EMSA DNA binding analysis of hZFP57zf3-4 point mutants at positions1 (hZFP
the ZF3 a-helical region. Where indicated (5) a ﬁvefold excess of the puriﬁed proteins w
1 (hZFP57zf3-4D270A); +2 (hZFP57zf3-4S272A), +3 (hZFP57zf3-4E273A) and +6 (hZFP57zf3-4R276A
proteins was added. (C) EMSA analysis of the hZFP57zf3-4E273A mutant DNA binding sensiti
and ZF4 are indicated; the regions which correspond to the a-helices are underlined and t
I. Baglivo et al. / FEBS Letters 587 (2013) 1474–1481 1477+3 (hZFP57zf3-4G245A) and +6 (hZFP57zf3-4R248A) and the ZF 4 mutant
in position +6 (hZFP57zf3-4R276A).
All the mutants showing a reduced but detectable DNA binding
capability have been tested in EMSA for their sensitivity to DNA
methylation and demonstrate to prefer the methylated target sites
(all the results obtained with the different mutants are
summarized in Suppl. Table 1). Interestingly, the ZF4 mutant
hZFP57zf3-4E273A shows similar afﬁnities toward the methylated
TGCmetCGC and non-methylated TGCCGC-containing oligonucleo-
tide (Fig. 3C). This result suggests that ZF 4 is involved in the
recognition of the methyl-cytosine and that the presence of
glutamate in position 273 plays a critical role in reducing the
afﬁnity to the unmethylated target.
Mackay and colleagues [3] have shown that patients affected by
TNDM1 have mutations in hZFP57 (Fig. 1). Two of these mutations,
R248H and H277N, affect residues in ZF 3 and ZF 4 respectively. In
order to test the effect of these mutations on hZFP57 DNA binding
capability, we have produced mutant versions of hZFP57zf1-4
bearing the mutations R248H and H277N. The EMSA presented
in Fig. 4 shows that both of these mutations cause loss of hZFP57
DNA binding capability.
In both mouse and human, PLAGL1 is transcribed from two CpG
island-associated promoters (Fig. 5A and E), of which the down-
stream one (P1) is methylated and imprinted and corresponds to
the ICR, while the upstream one (P2) is unmethylated [17,18]. Con-
sistent with previous results [6], we show that the ZFP57–KAP1
complex binds the imprinted but not the non-imprinted Plagl1 pro-
moter in mouse ESC (Fig. 5B). In addition, we observed that the
Plagl1 ICR is hypomethylated and P1agl1 expression derived from
the imprinted promoter is up-regulated in mouse Zfp57 / ESCs,
indicating that ZFP57 is a repressor of the Plagl1 gene (Fig. 5C and
D). The binding of KAP1 to the human TNDM1 ICR was demon-
strated in embryonic kidney HEK293 cells in a ChIPseq study con-
ducted by Farnham and co-workers [19]. By using locus-speciﬁc
ChIP, we observed that in human embryonal carcinoma 2102EpC
57zf3-4D242A); +2 (hZFP57zf3-4S244A), +3 (hZFP57zf3-4G245A) and +6 (hZFP57zf3-4R248A) of
as added. (B) EMSA DNA binding analysis of hZFP57zf3-4 point mutants at positions
) of the ZF4 a-helical region. Where indicated (5) a ﬁvefold excess of the puriﬁed
vity to cytosine methylation of the TGCCGC target site. The sequences of hZFP57 ZF3
he residues which have been mutated to alanine are in bold and in a larger font size.
Fig. 4. EMSA analysis of the DNA binding capability of the TNDM1 point mutants
hZFP571-4R248H and hZFP57zf1-4H277N. Where indicated (5) a ﬁvefold excess of the
puriﬁed proteins was added. The sequences of hZFP57 ZF3 and ZF4 are indicated;
the regions which correspond to the a-helices are underlined and the residues
which are mutated in TNDM1 are in bold and in a larger font size.
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ciently than the non-imprinted promoter, suggesting an imprinting
control mechanism based on ZFP57–KAP1 and similar to the
mouse (Fig. 5F).
In order to determine if the TNDM1 ICR is really able to bind
hZFP57, we tested by EMSA as DNA targets for hZFP57zf3-4 three
DNA sequences containing the TGCCGC motif identiﬁed in this re-
gion (PLAGL1-1, PLAGL1-2 and PLAGL1-3 see Fig. 5E and Supple-
mentary Fig. 2). The results demonstrate the DNA methylation-
dependent binding of hZFP57 to these sequences (Fig. 6). Consider-
ing that the PLAGL1-1 and the PLAGL1-2 sites are very close and
form a tight palindrome in the PLAGL1 promoter (see Supplemen-
tary Fig. 2) we also tested by EMSA an oligonucleotide containing
the palindrome. We found that, hZFP57zf3-4 binds the palindromic
repeat and is sensitive to the methylation of the cytosines present
in the two hexanucleotides. The methylation of the cytosine in the
spacer region does not affect the protein–DNA interaction (Supple-
mentary Fig. 3).
4. Discussion
Mouse and human ZFP57 contain three and six Cys2His2 ZFs
respectively, two of which, the ﬁrst and the second of the mouse
protein being homologous to the third and fourth of the human
protein. Our results on the human ZFP57 protein demonstrate that
the sequence extending from glycine 226 to valine 288, including
the third and the fourth ZFs, is sufﬁcient for high afﬁnity binding
to the methylated DNA target sites. With amino acid substitutions
of the canonical a-helical positions 1, +2, +3 and +6 involved in
ZF-DNA recognition [14,16], we show which residues of the ZFs 3
and 4 are important for hZFP57–DNA interaction. In addition, we
demonstrate that two hZFP57 mutations (R248H and H277N)associated with TNDM1 affect the binding to methylated DNA.
Furthermore, we show in mouse ESCs that Zfp57 inactivation
results in loss of DNA methylation and gene activation at the Plagl1
promoter. Finally, we identify three DNA sequences in the TNDM1
ICR showing DNA methylation-dependent binding to hZFP57, indi-
cating that either mutations in the critical ZF residues or hypome-
thylation of the target DNA sequences may result in loss of hZFP57
binding and PLAGL1 activation in TNDM1.
By analyzing single amino acid substitution mutants of the
hZFP57 DNA binding domain we demonstrated that substitution
of S244, G245 and R248, occupying position +2, +3 and +6 of ZF
3 a-helix and R276, located at position +6 of ZF4 helical region,
have a dramatic effect on the interaction with DNA. Weaker reduc-
tion of the DNA binding capability is observed when D242 (posi-
tion 1 ZF3), D270 (position 1 ZF4), S272 (position +2 ZF4) are
mutated to alanine. While aspartate, serine, glutamate and argi-
nine can act as base determinants, contact the phosphates or alter-
natively have a structural role to correctly position other residue
side chains, a glycine residue, which lacks a side chain, could
hardly be involved in a critical contact. For G245 we can then imag-
ine a sort of passive role in DNA recognition in which its presence
allows the a-helix to closely approach the nucleic acid. Our mu-
tants analysis also demonstrate that ZF4 residue E273, located in
position +3 of the helix, is important to reduce the binding to the
unmethylated target sites favoring the preferential recognition of
the methylated sequences. While this article was being written,
Cheng and co-workers published the structural characterization
of mouse ZFP57 ZF1 and ZF2 complexed to the methylated hexanu-
cleotide 50-TGCmetCGC-30 target site [20]. This study reveals that
the methylated DNA target is speciﬁcally recognized by residues
invariant between mouse and human; those residues are located
in the N-terminal portion of the helix and in the preceding loop
(positions 2, 1, +2, +3, and +6) of the ﬁrst and the second mouse
ZFP57 zinc ﬁngers. Interestingly, the two methylated cytosines are
asymmetrically recognized. One involves hydrophobic interactions
with ZF2 Arg176 (that occupies the non-canonical position 2 and
corresponds to ZF4 Arg269 in the human ZFP57) and the other re-
quires a layer of water molecules. Overall, the structural and func-
tional ﬁndings obtained for the mouse ZFP57 are in very good
agreement with the functional results of the human protein here
presented, and suggest that ZF4 Arg269 of human ZFP57 play a
key role in the speciﬁc recognition of the methylated site. Interest-
ingly, ZF1 and ZF2 of human ZFP57 are not conserved in the mouse
and are dispensable for high afﬁnity DNA binding to the methyl-
ated hexanucleotide 50-TGCmetCGC-30 target site; further investiga-
tions would be needed to clarify the exact role of these extra ﬁnger
domains, possibly involved in protein–protein interactions or in
the recognition of different target sites.
Recently, seven different recessive mutations in hZFP57 have
been identiﬁed as a cause for variable but stable mosaic hypome-
thylation at multiple imprinted loci in patients with TNDM1 [3].
Four of these ZFP57 mutations (E106VfsX28, C261X, G299fsX1
and G461GfsX17) generate truncated forms of the protein and
three (R248H, H277N and H458D) are missense mutations affect-
ing residues highly conserved among several mammalian species
(see Fig. 1). We demonstrated that two of the missense mutations
(R248H and H277N), affecting position +6 of ZF 3 and one of the
zinc-binding histidines within ZF 4 respectively, alter hZFP57
DNA binding capability. The 2-bp deletion in the KRAB domain
(E106VfsX28) causing a frameshift and generating a premature
translation termination codon would produce a short protein lack-
ing the entire ZF containing region which certainly is not able to
bind DNA. Interestingly, on the basis of our results we can argue
that also the truncating substitution C261X, changing the ﬁrst cys-
teine of ZF4 into a stop codon, generates a protein unable to recog-
nize the DNA target with adequate afﬁnity because it is missing the
Fig. 5. ChIP, DNA methylation and expression analyses of the PLAGL1 locus in mouse and human cells. (A) Screen shot of the UCSC genome browser showing the mouse Plagl1
transcripts derived from the imprinted (P1) and the non-imprinted (P2) promoters. The location of CpGi 36 and CpGi 72 corresponding to a non-methylated CpG island and
the Plagl1 ICR, respectively, and the exameric ZFP57 motifs are indicated. (B) Analysis of ZFP57 and KAP1 binding by ChIP at CpGi 36 and CpGi 72 in mouse wildtype and Zfp57
/ ESCs. The amount of target DNA enrichment was estimated by q-PCR and expressed as percent of input. Data represent the average of three independent experiments. (C)
DNA methylation analysis of the Plagl1 ICR (CpGi 72) as assessed by bisulﬁte sequencing. Each row of circles represents the results of an independent sequencing reaction.
Open and ﬁlled circles indicate unmethylated and methylated CpGs, respectively. The location of the ZFP57 hexameric target sequences is indicated by arrows. (D) Expression
of the Plagl1 transcripts in mouse wildtype and Zfp57 / ESCs as assessed by quantitative RT-PCR. The RNA was analyzed with primers speciﬁc for the P1-Plagl1 and P2-
Plagl1 transcripts. The results obtained with one clone of Zfp57/ ESCs are shown. The analysis of a second clone gave comparable results (not shown). (E) Screen shot of the
UCSC genome browser showing the human PLAGL1 transcripts derived from the imprinted (P1) and the non-imprinted (P2) promoters. The location of CpGi 113 and CpGi 118
corresponding to a non-methylated CpG island and the TNDM1 ICR, respectively, and the exameric ZFP57 motifs are indicated. (F) Analysis of KAP1 binding by ChIP at CpGi
113 and CpGi 118 in 2102Ep cells. The amount of target DNA enrichment was estimated by q-PCR and expressed as percent of input. Data represent the average of three
independent experiments.
I. Baglivo et al. / FEBS Letters 587 (2013) 1474–1481 1479entire C-terminus, including the DNA-contacting ZF4 domain. The
truncating mutations G299fsX1 and G461GfsX17 and the missense
mutation H458D, mapping in the putative seventh ZF domain lack-
ing the fourth coordinating residue, generate proteins including
the KRAB domain and the entire DNA-binding ZFs region. Since
the clinical features of the patients bearing the ZFP57 mutations
in the C-terminal half of the protein are indistinguishable from
the others, it is likely that the protein products of these mutantgenes are equally not functional. Further studies are required to
ﬁnd out whether these mutations reduce the protein stability or
if the C-terminal part of the protein, including ZF5 and ZF6, is di-
rectly involved in protein function.
ZFP57 is necessary for the maintenance of DNA methylation at
the ICRs and its loss results in activation of some imprinted genes
in mouse embryos and ESCs [5,6]. We extended this analysis fur-
ther and demonstrated that ZFP57 represses Plagl1 expression
Fig. 6. EMSA DNA binding analysis of hZFP57zf3-4 on the three putative ZFP57 DNA target sequences (PLAGL1-1, PLAGL1-2 and PLAGL1-3) identiﬁed in the TNDM1 ICR. The
sequences of the oligonucleotides used as probes are indicated.
1480 I. Baglivo et al. / FEBS Letters 587 (2013) 1474–1481derived from the imprinted promoter and maintains it methylated
in mouse ESCs. A ChIPseq analysis performed by Farnham and co-
workers [19] and a locus-speciﬁc ChIP performed in this study
show the binding of KAP1 to the TNDM1 ICR and in vitro binding
assays demonstrate that this sequence is indeed able to bind
hZFP57 if methylated.
The causes of isolated loss of PLAGL1 methylation and multiple
hypomethylation of imprinted loci (HIL) without ZFP57 mutations
demonstrated in TNDM1 are unknown. They may include environ-
mental factors, reproductive errors or genetic mutations at loci dif-
ferent from ZFP57. The elevated incidence of assisted reproduction
in patients with TNDM1 and HIL but without ZFP57 mutations,
although not statistically signiﬁcant, may indicate a possible factor
in the etiology of at least some of these cases [1]. Whatever the
cause of loss of methylation would be, our data suggest that in
these patients the lack of methylation on the maternal allele of
the 6q24 TNDM1 ICR would reduce the recruitment of the repres-
sor ZFP57/KAP1 complex on this site and alter the expression of the
imprinted genes PLAGL1 and HYMAI.
Acknowledgements
This study has been funded by Programma MERIT
RBNE08HWLZ_014 (to P.V.P.), MIUR PRIN 2009 and Telethon-Italia
grant no. GGP11122 (to A.R.), and Progetto Bandiera MIUR-CNR
Epigenomica and People Programme (Marie Curie Actions) of the
European Union’s Seventh Framework Programme FP7/2007-
2013/ under REA grant agreement n 290123 (to A.R. and G.G.).
We thank T. Yokota and T. Akagi for the gift of Zfp57/ cells.
We are greatful to Marco Mammucari and Maurizio Muselli for
excellent technical assistance.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
theonlineversion, at http://dx.doi.org/10.1016/j.febslet.2013.02.045.
References
[1] Mackay, D.J.G. and Temple, I.K. (2010) Transient neonatal diabetes mellitus
type 1. Am. J. Med. Genet. Part C Semin. Med. Genet. 154C, 335–342.[2] Temple, I.K. and Shield, J.P.H. (2010) 6q24 Transient neonatal diabetes. Rev.
Endocr. Metab. Disord. 11, 199–204.
[3] Mackay, D.J.G., Callaway, J.L., Marks, S.M., White, H.E., Acernini, C.L., Boonen,
S.E., Dayanikli, P., Firth, H.V., Goodship, J.A., Hahnemann, J.M., Kordonouri, O.,
Masoud, A.F., Oestergaard, E., Storr, J., Ellard, S., Httersley, A.T., Robinson, D.O.
and Temple, I.K. (2008) Hypomethylation of multiple imprinted loci in
patients with transient neonatal diabetes is associated with mutations in
ZFP57. Nat. Genet. 40, 949–951.
[4] Alonso, M.B., Zoidl, G., Taveggia, C., Bosse, F., Zoidl, C., Rahman, M., Parmantier,
E., Dean, C.H., Harris, B.S., Wrabetz, L., Muller, H.W., Jessen, K.R. and Mirsky, R.
(2004) Identiﬁcation and characterization of ZFP-57, a novel zinc ﬁnger
transcription factor in the mammalian peripheral nervous system. J. Biol.
Chem. 279, 25653–25664.
[5] Li, X., Ito, M., Zhou, F., Youngson, N., Zuo, X., Ledeer, P. and Ferguson-Smith,
A.C. (2008) A maternal-zygotic effect gene, Zfp57, maintains both maternal
and paternal imprints. Dev. Cell 15, 547–557.
[6] Quenneville, S., Verde, G., Corsinotti, A., Kapopoulou, A., Jakobsson, J., Offner, J.,
Baglivo, I., Pedone, P.V., Grimaldi, G., Riccio, A. and Trono, D. (2011) In
embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to
affect chromatin and DNA methylation of imprinting control regions. Mol. Cell
44, 361–372.
[7] Zuo, X., Sheng, J., Lau, H., McDonald, C.M., Andrade, M., Cullen, D.E., Bell, F.T.,
Iacovino, M., Kyba, M., Xu, G. and Li, X. (2011) The zinc ﬁnger protein ZFP57
requires its cofactor to recruit DNA methyltransferases and maintains the DNA
methylation imprint in embryonic stem cells via its transcriptional repression
domain. J. Biol. Chem. 287, 2107–2118.
[8] Messerschmidt, D.M., de Vries, W., Ito, M., Solter, D., Fergouson-Smith, A. and
Knowles, B.B. (2012) Trim28 is required for epigenetic stability during mouse
occyte to embryo transition. Science 335, 1499–1502.
[9] Delidow, B.C., Lynch, J.P., Peluso, J.J. and White, B.A. (1993) Polymerase chain
reaction: basic protocols. Methods Mol. Biol. 15, 1–29.
[10] Esposito, S., Baglivo, I., Malgieri, G., Russo, L., Zaccaro, L., D’Andrea, L.D.,
Mammucari, M., Di Blasio, B., Isernia, C., Fattorusso, R. and Pedone, P.V. (2006)
A novel type of zinc ﬁnger DNA binding domain in the Agrobacterium
tumefaciens transcriptional regulator Ros. Biochemistry 45, 10394–10405.
[11] Akagi, T., Usuda, M., Matsuda, T., Ko, M.S., Niwa, H., Asano, M., Koide, H. and
Yokota, T. (2005) Identiﬁcation of Zfp-57 as a downstream molecule of STAT3
and Oct-3/4 in embryonic stem cells. Biochem. Biophys. Res. Commun. 331,
23–30.
[12] Azuma, S. and Toyoda, Y. (1991) Production of a germ-line chimeric mouse
derived from newly established embryonic stem cells. Jpn. J. Anim. Reprod. 37,
37–43.
[13] Hirasawa, R. and Feil, R. (2008) A KRAB domain zinc ﬁnger protein in
imprinting and disease. Dev. Cell 15, 487–488.
[14] Wolfe, S.A., Nekludova, L. and Pabo, C.O. (2000) DNA recognition by Cys2His2
zinc ﬁnger proteins. Annu. Rev. Biophys. Biomol. Struct. 29, 183–212.
[15] Renda, M., Baglivo, I., Burgess-Beusse, B., Esposito, S., Fattorusso, R., Felsenfeld,
G. and Pedone, P.V. (2007) Critical DNA binding interactions of the insulator
protein CTCF: a small number of zinc ﬁngers mediate strong binding, and a
single ﬁnger–DNA interaction controls binding at imprinted loci. J. Biol. Chem.
282, 33336–33345.
[16] Klug, A. and Schwabe, J.W.R. (1995) Protein motifs 5. Zinc ﬁnger. FASEB J. 9,
597–604.
I. Baglivo et al. / FEBS Letters 587 (2013) 1474–1481 1481[17] Iglesias-Platas, I., Martin-Trujillo, A., Cirillo, D., Court, F., Guillaumet-Adkins,
A., Camprubi, C., Bourc’his, D., Hata, K., Feil, R., Tartaglia, G., Arnaud, P. and
Monk, D. (2012) Characterization of novel paternal ncRNAs at the Plagl1 locus,
including Hymai, predicted to interact with regulators of active chromatin.
PLoS One 7, e38907.
[18] Valleley, E.M., Cordery, S.F. and Bonthron, D.T. (2007) Tissue-speciﬁc
imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variableutilization of monoallelic and biallelic promoters. Hum. Mol. Genet. 16, 972–
981.
[19] Iyengar, S., Ivanov, A.V., Jin, V.X., Rauscher 3rd, F.J. and Farnham, P.J. (2011)
Functional analysis of KAP1 genomic recruitment. Mol. Cell. Biol. 31, 1833–1847.
[20] Liu, Y., Toh, H., Sasaki, H., Zhang, X. and Cheng, X. (2012) An atomic model of
Zfp57 recognition of CpG methylation within a speciﬁc DNA sequence. Genes
Dev. 26, 2374–2379.
